Large-scale clinical trials have demonstrated that GLP-1RAs reduce the incidence of major adverse cardiovascular events (MACE), including myocardial infarction (MI) and stroke, through metabolic, anti-inflammatory, and direct cardiac mechanisms in both diabetic and non-diabetic populations [316,317,318]
Lear more about G-protein signaling
Ruhoy had several patients where the drugs didnt seem to make much of a difference at first, but were, she said, an astounding success by week three or four
For some patients, the next step after medical stabilization is structured training through PSFM Wellness or a more performance-oriented bridge at Fuse Sports Performance
The good news is that GLP-1 receptor agonists can be safely used in people with high blood pressure, and evidence suggests they may offer additional benefits for blood pressure control
I dont feel like Im dragging anymore. So far, he has experienced no side effects and plans to continue microdosing as long as his A1C and cholesterol numbers stay within the normal range
